rs111663599

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002666.5(PLIN1):​c.466G>T​(p.Val156Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,614,048 control chromosomes in the GnomAD database, including 199 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 23 hom., cov: 32)
Exomes 𝑓: 0.011 ( 176 hom. )

Consequence

PLIN1
NM_002666.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.219

Publications

9 publications found
Variant links:
Genes affected
PLIN1 (HGNC:9076): (perilipin 1) The protein encoded by this gene coats lipid storage droplets in adipocytes, thereby protecting them until they can be broken down by hormone-sensitive lipase. The encoded protein is the major cAMP-dependent protein kinase substrate in adipocytes and, when unphosphorylated, may play a role in the inhibition of lipolysis. Alternatively spliced transcript variants varying in the 5' UTR, but encoding the same protein, have been found for this gene. [provided by RefSeq, Feb 2009]
PLIN1 Gene-Disease associations (from GenCC):
  • PLIN1-related familial partial lipodystrophy
    Inheritance: AD Classification: STRONG, SUPPORTIVE, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034962893).
BP6
Variant 15-89670112-C-A is Benign according to our data. Variant chr15-89670112-C-A is described in ClinVar as Benign. ClinVar VariationId is 393439.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0104 (1583/152340) while in subpopulation NFE AF = 0.0122 (828/68026). AF 95% confidence interval is 0.0115. There are 23 homozygotes in GnomAd4. There are 902 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1583 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLIN1NM_002666.5 linkc.466G>T p.Val156Leu missense_variant Exon 5 of 9 ENST00000300055.10 NP_002657.3 O60240
PLIN1NM_001145311.2 linkc.466G>T p.Val156Leu missense_variant Exon 5 of 9 NP_001138783.1 O60240

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLIN1ENST00000300055.10 linkc.466G>T p.Val156Leu missense_variant Exon 5 of 9 1 NM_002666.5 ENSP00000300055.5 O60240
PLIN1ENST00000430628.2 linkc.466G>T p.Val156Leu missense_variant Exon 5 of 9 5 ENSP00000402167.2 O60240

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1585
AN:
152222
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00150
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00641
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0531
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0122
Gnomad OTH
AF:
0.00573
GnomAD2 exomes
AF:
0.0125
AC:
3136
AN:
250760
AF XY:
0.0125
show subpopulations
Gnomad AFR exome
AF:
0.00142
Gnomad AMR exome
AF:
0.00411
Gnomad ASJ exome
AF:
0.00348
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0518
Gnomad NFE exome
AF:
0.0152
Gnomad OTH exome
AF:
0.0123
GnomAD4 exome
AF:
0.0110
AC:
16084
AN:
1461708
Hom.:
176
Cov.:
35
AF XY:
0.0107
AC XY:
7764
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.00114
AC:
38
AN:
33474
American (AMR)
AF:
0.00465
AC:
208
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00268
AC:
70
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00107
AC:
92
AN:
86224
European-Finnish (FIN)
AF:
0.0538
AC:
2870
AN:
53376
Middle Eastern (MID)
AF:
0.0102
AC:
59
AN:
5768
European-Non Finnish (NFE)
AF:
0.0109
AC:
12160
AN:
1111930
Other (OTH)
AF:
0.00972
AC:
587
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
983
1966
2948
3931
4914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0104
AC:
1583
AN:
152340
Hom.:
23
Cov.:
32
AF XY:
0.0121
AC XY:
902
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00149
AC:
62
AN:
41586
American (AMR)
AF:
0.00634
AC:
97
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5190
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4824
European-Finnish (FIN)
AF:
0.0531
AC:
564
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0122
AC:
828
AN:
68026
Other (OTH)
AF:
0.00567
AC:
12
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
82
164
247
329
411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0113
Hom.:
46
Bravo
AF:
0.00691
TwinsUK
AF:
0.00944
AC:
35
ALSPAC
AF:
0.0117
AC:
45
ESP6500AA
AF:
0.000909
AC:
4
ESP6500EA
AF:
0.0110
AC:
95
ExAC
AF:
0.0134
AC:
1622
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0119
EpiControl
AF:
0.0129

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PLIN1: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Monogenic diabetes Benign:1
Feb 01, 2019
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG criteria: BP4 (REVEL 0.046 + 8 predictors), not using PP3 (2 predictors)), BA1 (5.3% in gnomAD EF, MAF 1.5% overall), BS2 (204 cases and 197 controls in type2diabetesgenetics.org)= benign -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
13
DANN
Benign
0.97
DEOGEN2
Benign
0.28
T;T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.58
.;T
MetaRNN
Benign
0.0035
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M;M
PhyloP100
0.22
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.046
Sift
Uncertain
0.021
D;D
Sift4G
Benign
0.16
T;T
Polyphen
0.095
B;B
Vest4
0.090
MutPred
0.67
Gain of helix (P = 0.0696);Gain of helix (P = 0.0696);
MPC
0.028
ClinPred
0.011
T
GERP RS
0.41
Varity_R
0.10
gMVP
0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111663599; hg19: chr15-90213343; COSMIC: COSV55584816; COSMIC: COSV55584816; API